Neutra Life Sciences forms women's health JV, adds new trials

Neutra Corp (OTC: NTRR) announced that its subsidiary Neutra Life Sciences has executed a joint venture partnership with Women's Healthcare Center of Baytown, opening a new clinical research site in Baytown, Texas, focused on women's health and OB/GYN specialties.

The subsidiary, which launched in 2025 and operates as a clinical research Site Management Organization (SMO), also reported it was awarded new clinical trials in oncology, dermatology, pulmonology, and women's health. Neutra Life Sciences said it secured new contracts with new sponsors as well as additional contracts with existing sponsors.

"Growing into a multi-therapeutic site network was done with intention," said Sydney Jim, President and CEO of Neutra Life Sciences. "This new joint venture and the launch of our women's health site solidify our growth strategy, and we are proud to extend OB/GYN clinical trial access to patients."

According to a company press release, Neutra Life Sciences has developed standardized site operating procedures, an expanding investigator base, and a track record of regulatory-compliant trial execution since its formation.

"Being awarded studies in new therapeutic areas and signing new sponsor contracts is a direct result of the operational discipline we've built over the past year," Jim added.

Neutra Corp said it expects continued growth across existing and new therapeutic areas in the third and fourth quarters of 2026, including additional trial opportunities and further expansion of sponsor and contract research organization relationships.

You May Also Be Interested In

• Spirit Blockchain Capital names Suha Askary as CEO
• Autonomix Medical reports renal nerve sensing results in animal study
• Verizon secures $1B+ dark fiber deal with Google